§

Ex Parte Schaebitz et al

11931326 (P.T.A.B. Dec. 11, 2012)
Ex Parte Schaebitz et al

16 Cited authorities

  1. Net Moneyin v. Verisign

    545 F.3d 1359 (Fed. Cir. 2008)   Cited 284 times   6 Legal Analyses
    Holding that, to anticipate, a single prior art reference must not only disclose all the limitations claimed but also must disclose those limitations "arranged or combined in the same way as recited in the claim"

  2. In re Gleave

    560 F.3d 1331 (Fed. Cir. 2009)   Cited 150 times
    Finding that the prior art reference was enabling and stating that “the fact that [the reference] provides ‘no understanding of which of the targets would be useful’ is of no import, because [the patent applicant] admits that it is well within the skill of an ordinary person in the art to make any oligodeoxynucleotide sequence”

  3. Impax v. Aventis Pharma

    545 F.3d 1312 (Fed. Cir. 2008)   Cited 68 times
    Stating that defenses of obviousness and anticipation must be proven by clear and convincing evidence

  4. Agilent Tech. v. Affymetrix

    567 F.3d 1366 (Fed. Cir. 2009)   Cited 51 times   5 Legal Analyses
    Reversing the district court's holding that an applicant's written description was adequate because the court erred in its claim construction

  5. In re Oelrich

    666 F.2d 578 (C.C.P.A. 1981)   Cited 94 times   6 Legal Analyses
    Stating that "[t]he mere fact that a certain thing may result from a given set of circumstances is not sufficient" to establish inherency (quoting Hansgirg v. Kemmer , 102 F.2d 212, 214 (C.C.P.A. 1939) )

  6. Rasmusson v. Smithkline Beecham Corp.

    413 F.3d 1318 (Fed. Cir. 2005)   Cited 43 times   4 Legal Analyses
    Explaining "proof of efficacy is not required in order for a reference to be enabled for purposes of anticipation"

  7. In re Oetiker

    977 F.2d 1443 (Fed. Cir. 1992)   Cited 66 times   9 Legal Analyses
    Reversing for "improperly combined" references, because "[i]f examination at the initial stage does not produce a prima facie case of unpatentability, then without more the applicant is entitled to grant of the patent"

  8. Application of Petering

    301 F.2d 676 (C.C.P.A. 1962)   Cited 76 times   7 Legal Analyses
    Holding in a case involving twenty compounds that a general chemical formula will anticipate a claimed species covered by the formula when the species can be `at once envisaged' from the formula

  9. Application of Arkley

    455 F.2d 586 (C.C.P.A. 1972)   Cited 45 times   1 Legal Analyses
    Noting that an anticipating reference "must clearly and unequivocally disclose the claimed compound or direct those skilled in the art to the compound without any need for picking, choosing, and combining various disclosures not directly related to each other by the teachings of the cited reference"

  10. Hansgirg v. Kemmer

    102 F.2d 212 (C.C.P.A. 1939)   Cited 57 times   3 Legal Analyses

    Patent Appeal No. 4077. February 27, 1939. Appeal from the Board of Patent Appeals, Interference No. 73,230. Interference proceeding between Fritz Hansgirg and Frank R. Kemmer. From a decision of the Board of Appeals of the United States Patent Office affirming decision of the Examiner of Interferences, the former appeals. Reversed. Brown, Critchlow Flick, of Pittsburgh, Pa. (Jo. Baily Brown and Fulton B. Flick, both of Pittsburgh, Pa., of counsel), for appellant. H.C. Bierman, of New York City,

  11. Section 103 - Conditions for patentability; non-obvious subject matter

    35 U.S.C. § 103   Cited 6,174 times   493 Legal Analyses
    Holding the party seeking invalidity must prove "the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains."

  12. Section 102 - Conditions for patentability; novelty

    35 U.S.C. § 102   Cited 6,034 times   1029 Legal Analyses
    Prohibiting the grant of a patent to one who "did not himself invent the subject matter sought to be patented"

  13. Section 6 - Patent Trial and Appeal Board

    35 U.S.C. § 6   Cited 189 times   63 Legal Analyses
    Giving the Director authority to designate "at least 3 members of the Patent Trial and Appeal Board" to review "[e]ach appeal, derivation proceeding, post-grant review, and inter partes review"

  14. Section 134 - Appeal to the Patent Trial and Appeal Board

    35 U.S.C. § 134   Cited 99 times   30 Legal Analyses

    (a) PATENT APPLICANT.-An applicant for a patent, any of whose claims has been twice rejected, may appeal from the decision of the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. (b) PATENT OWNER.-A patent owner in a reexamination may appeal from the final rejection of any claim by the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. 35 U.S.C. § 134 July 19, 1952, ch. 950, 66 Stat. 801; Pub. L. 98-622

  15. Section 41.37 - Appeal brief

    37 C.F.R. § 41.37   Cited 32 times   25 Legal Analyses
    Requiring identification of support in specification and, for means-plus-function limitations, corresponding structure as well

  16. Section 1.136 - [Effective until 1/19/2025] Extensions of time

    37 C.F.R. § 1.136   Cited 17 times   30 Legal Analyses

    (a) (1) If an applicant is required to reply within a nonstatutory or shortened statutory time period, applicant may extend the time period for reply up to the earlier of the expiration of any maximum period set by statute or five months after the time period set for reply, if a petition for an extension of time and the fee set in § 1.17(a) are filed, unless: (i) Applicant is notified otherwise in an Office action; (ii) The reply is a reply brief submitted pursuant to § 41.41 of this title; (iii)